DAVID ROBERT SMITH
Allopathic & Osteopathic Physicians|Pediatrics HUTCHINSON, KS NPI 1306134044
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics KS Supernus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$362.00
- Category: General Payments
- Program years: PY2019–2024
- Record count: 18
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $209.69 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $209.69 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $68.63 | 1 |
| PFIZER INC. | $53.46 | 3 |
| VERTEX PHARMACEUTICALS INCORPORATED | $28.03 | 1 |
| ABBVIE INC. | $22.86 | 1 |
| Axsome Therapeutics, Inc. | $19.73 | 1 |
| Novo Nordisk AS | $16.98 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1097662717 | Novo Nordisk Inc | $16.98 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105912364 | VERTEX PHARMACEUTICALS INCORPORATED | $28.03 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106122688 | ABBVIE INC. | $22.86 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131395797 | PFIZER INC. | $17.37 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131758822 | PFIZER INC. | $19.35 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132086636 | PFIZER INC. | $16.74 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147877125 | Supernus Pharmaceuticals, Inc. | $68.63 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148276176 | Axsome Therapeutics, Inc. | $19.73 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.